US2012329835A1PendingUtilityA1
Use of 1-hydroxy-2- pyridones for the treatment of seborrheic dermatitis
Est. expirySep 27, 2016(expired)· nominal 20-yr term from priority
A61P 17/00A61P 17/08A61K 8/4926A61Q 19/00A61K 31/4412A61Q 5/02A61Q 5/006
52
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Compounds of the formula (1) are disclosed and are suitable for the treatment of seborrheic dermatitis.
Claims
exact text as granted — not AI-modified1 - 13 . (canceled)
14 . A solid pharmaceutical formulation comprising
One or more 1-hydroxy-2-pyridones selected from the group consisting of ciclopirox and octopirox; and One or more surfactants.
15 . The formulation of claim 14 wherein the formulation has a pH of 4.5 to 6.5.
16 . The formulation of claim 14 wherein the 1-hydroxy-2-pyridone is ciclopirox.
17 . The formulation of claim 14 wherein the 1-hydroxy-2-pyridones are present in a concentration of 0.2% to 10% by weight of the formulation.
18 . The formulation of claim 14 wherein the 1-hydroxy-2-pyridones are present in a concentration of 0.5% to 2% by weight of the formulation.
19 . A method of treating seborrheic dermatitis comprising
Wetting and lathering a solid pharmaceutical formulation, wherein the formulation comprises one or more 1-hydroxy-2-pyridones selected from the group consisting of ciclopirox and octopirox; and one or more surfactants, Applying the formulation to the skin, and Washing off the formulation.
20 . The method of claim 19 wherein the formulation has a pH of 4.5 to 6.5.
21 . The method of claim 19 wherein the 1-hydroxy-2-pyridone is ciclopirox.
22 . The method of claim 19 wherein the 1-hydroxy-2-pyridones are present in a concentration of 0.2% to 10% by weight of the formulation.
23 . The method of claim 19 wherein the 1-hydroxy-2-pyridones are present in a concentration of 0.5% to 2% by weight of the formulation.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.